​The weakening of the Norwegian krone and the corona pandemic led to a need to improve the profitability of stepped price medicines and reduce the financial risk to which suppliers are exposed.

The Norwegian Medicines Agency implemented a temporary increase in all stepped prices from 15 May to 14 August 2020.


​Fant du det du lette etter?